All the news Showing 4 of 4 articles from: EASL 2019Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources NAFLD Experts warn of fatty liver disease 'epidemic' in young people The Guardian / 12 April 2019 Access to medicines & diagnostics Global hepatitis response gains ground – More action needed to achieve universal health coverage targets World Health Organization / 12 April 2019 NAFLD Second-generation thiazolidinedione, MSDC-0602K may significantly improve liver enzymes, fibrosis, and glycaemic markers with minimal adverse events, according to a Phase 2b study EASL / 12 April 2019 Treatment for previous non-responders & relapsers ‘Real-world’ studies in Germany and the USA confirm high rates of sustained virological response with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) in individuals with chronic HCV infection failing DAAs EASL / 12 April 2019 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive